The Motley Fool

PARA BIO FPO (ASX: PAR) Share Price and News

 Chart and Price Data

20mins delayed

Bid/Ask /
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...


healthcare shares

Is Paradigm the real deal blockbuster biotech?

Paradigm is a speculative biotech business exciting investors with news over its Zilosul drug's potential to treat osteoarthritis. More »

share price higher

Why the Polynovo share price is now up 24x in 5 years

The Polynovo Ltd (ASX: PNV) share price is up 7% to $2.43 this lunchtime despite the biotech not releasing any specific news to the... More »

Healthy Heart

The Orthocell share price is going nuts on claims of a blockbuster medical breakthrough

Orthocell Ltd (ASX: OCC) is reporting a blockbuster medical breakthrough. More »

ASX shares soaring higher

Why these ASX shares just stormed to 52-week highs

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of three that just raced to 52-week highs or better... More »

Mesoblast shares halted as it asks investors to tip in another $75 million

Mesoblast limited (ASX: MSB) needs more capital from investors. More »


US congressman resigns over ASX insider trading penny stock scandal

Can you make money in penny stocks? More »

watch, watch list, observe, keep an eye on

5 small-cap shares I’m watching in FY 2020

Serko Ltd (ASX: SKO) and 4 other small-cap ASX companies worth watching in FY20. More »

invest chart up

Why Nufarm, Paradigm, ResApp, & Zip Co shares charged higher today

The Nufarm Limited (ASX:NUF) share price and the Zip Co Ltd (ASX:Z1P) share price are two of four charging higher... More »

bull vs bear

Paradigm reports “ground-breaking” osteoarthritis discovery: Is it the real deal?

Paradigm Biopharmaceuticals (ASX:PAR) is looking to partner with big pharma. More »

Winners Cup Trophy

Is Paradigm Biopharmaceuticals the share market’s next huge winner?

Paradigm: Buy the rumour, sell the news? More »

Why the Bionomics share price is up 40% today

Bionomics Ltd (ASX: BNO) looks very speculative. More »

Paradigm share price tanks despite positive clinical trial update

Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar. More »

Rocket soaring through the sky

Why the Mesoblast share price is going nuts today

Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal. More »

bull and bear figurines facing off over stockmarket graph

Opthea share price lifts on clinical trial update: Is it a spec buy?

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »